Advertisement
Screener

Quest Diagnostics Inc (DGX) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

Quest Diagnostics Inc Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

Quest Diagnostics Inc (DGX) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of $315.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-23

  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $315.00M, a 13.22% decline year-over-year.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $248.00M, a 3.33% increase year-over-year.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $269.00M, a 65.03% increase year-over-year.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $235.00M, a 2.49% decline year-over-year.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $1.11B, a 30.70% increase from fiscal 2024.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $847.00M, a 7.43% decline from fiscal 2023.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $915.00M, a 9.23% decline from fiscal 2022.
  • Quest Diagnostics Inc comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $1.01B, a 51.70% decline from fiscal 2021.
Period endComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30$315.00M
10-Q · filed 2026-07-23
$563.00M
10-Q · filed 2026-07-23
$832.00M
derived: sum of 3 quarters · filed 2026-07-23
$1.07B
derived: sum of 4 quarters · filed 2026-07-23
2026-03-31$248.00M
10-Q · filed 2026-04-22
$517.00M
derived: sum of 2 quarters · filed 2026-04-22
$752.00M
derived: sum of 3 quarters · filed 2026-04-22
$1.11B
derived: sum of 4 quarters · filed 2026-07-23
2025-12-31$269.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$504.00M
derived: sum of 2 quarters · filed 2026-02-26
$867.00M
derived: sum of 3 quarters · filed 2026-07-23
$1.11B
10-K · filed 2026-02-26
2025-09-30$235.00M
10-Q · filed 2025-10-21
$598.00M
derived: sum of 2 quarters · filed 2026-07-23
$838.00M
10-Q · filed 2025-10-21
$1.00B
derived: sum of 4 quarters · filed 2026-07-23
2025-06-30$363.00M
10-Q · filed 2026-07-23
$603.00M
10-Q · filed 2026-07-23
$766.00M
derived: sum of 3 quarters · filed 2026-07-23
$1.01B
derived: sum of 4 quarters · filed 2026-07-23
2025-03-31$240.00M
10-Q · filed 2026-04-22
$403.00M
derived: sum of 2 quarters · filed 2026-04-22
$644.00M
derived: sum of 3 quarters · filed 2026-04-22
$881.00M
derived: sum of 4 quarters · filed 2026-04-22
2024-12-31$163.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$404.00M
derived: sum of 2 quarters · filed 2026-02-26
$641.00M
derived: sum of 3 quarters · filed 2026-02-26
$847.00M
10-K · filed 2026-02-26
2024-09-30$241.00M
10-Q · filed 2025-10-21
$478.00M
derived: sum of 2 quarters · filed 2025-10-21
$684.00M
10-Q · filed 2025-10-21
$895.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$237.00M
10-Q · filed 2025-07-23
$443.00M
10-Q · filed 2025-07-23
$654.00M
derived: sum of 3 quarters · filed 2026-02-26
$887.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$206.00M
10-Q · filed 2025-04-23
$417.00M
derived: sum of 2 quarters · filed 2026-02-26
$650.00M
derived: sum of 3 quarters · filed 2026-02-26
$901.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$211.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$444.00M
derived: sum of 2 quarters · filed 2026-02-26
$695.00M
derived: sum of 3 quarters · filed 2026-02-26
$915.00M
10-K · filed 2026-02-26
2023-09-30$233.00M
10-Q · filed 2024-10-23
$484.00M
derived: sum of 2 quarters · filed 2024-10-23
$704.00M
10-Q · filed 2024-10-23
$830.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$251.00M
10-Q · filed 2024-07-24
$471.00M
10-Q · filed 2024-07-24
$597.00M
derived: sum of 3 quarters · filed 2025-02-20
$865.00M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$220.00M
10-Q · filed 2024-04-24
$346.00M
derived: sum of 2 quarters · filed 2025-02-20
$614.00M
derived: sum of 3 quarters · filed 2025-02-20
$857.00M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$126.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$394.00M
derived: sum of 2 quarters · filed 2025-02-20
$637.00M
derived: sum of 3 quarters · filed 2025-02-20
$1.01B
10-K · filed 2025-02-20
2022-09-30$268.00M
10-Q · filed 2023-10-25
$511.00M
derived: sum of 2 quarters · filed 2023-10-25
$882.00M
10-Q · filed 2023-10-25
$1.29B
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$243.00M
10-Q · filed 2023-07-27
$614.00M
10-Q · filed 2023-07-27
$1.03B
derived: sum of 3 quarters · filed 2024-02-22
$1.55B
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$371.00M
10-Q · filed 2023-04-28
$783.00M
derived: sum of 2 quarters · filed 2024-02-22
$1.31B
derived: sum of 3 quarters · filed 2024-02-22
$1.98B
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$412.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$936.00M
derived: sum of 2 quarters · filed 2024-02-22
$1.61B
derived: sum of 3 quarters · filed 2024-02-22
$2.09B
10-K · filed 2024-02-22
2021-09-30$524.00M
10-Q · filed 2022-10-21
$1.20B
derived: sum of 2 quarters · filed 2022-10-21
$1.68B
10-Q · filed 2022-10-21
$2.31B
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30$671.00M
10-Q · filed 2022-07-22
$1.15B
10-Q · filed 2022-07-22
$1.78B
derived: sum of 3 quarters · filed 2023-02-21
$2.38B
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31$480.00M
10-Q · filed 2022-04-22
$1.11B
derived: sum of 2 quarters · filed 2023-02-21
$1.71B
derived: sum of 3 quarters · filed 2023-02-21
$1.91B
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31$630.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$1.23B
derived: sum of 2 quarters · filed 2023-02-21
$1.43B
derived: sum of 3 quarters · filed 2023-02-21
$1.52B
10-K · filed 2023-02-21
2020-09-30$604.00M
10-Q · filed 2021-10-22
$800.00M
derived: sum of 2 quarters · filed 2021-10-22
$887.00M
10-Q · filed 2021-10-22
$1.17B
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$196.00M
10-Q · filed 2021-07-23
$283.00M
10-Q · filed 2021-07-23
$564.00M
derived: sum of 3 quarters · filed 2022-02-28
$793.00M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$87.00M
10-Q · filed 2021-04-23
$368.00M
derived: sum of 2 quarters · filed 2022-02-28
$597.00M
derived: sum of 3 quarters · filed 2022-02-28
$833.00M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$281.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$510.00M
derived: sum of 2 quarters · filed 2022-02-28
$746.00M
derived: sum of 3 quarters · filed 2022-02-28
$926.00M
10-K · filed 2022-02-28
2019-09-30$229.00M
10-Q · filed 2020-10-23
$465.00M
derived: sum of 2 quarters · filed 2020-10-23
$645.00M
10-Q · filed 2020-10-23
$783.00M
derived: sum of 4 quarters · filed 2021-02-22
2019-06-30$236.00M
10-Q · filed 2020-07-24
$416.00M
10-Q · filed 2020-07-24
$554.00M
derived: sum of 3 quarters · filed 2021-02-22
$780.00M
derived: sum of 4 quarters · filed 2021-02-22
2019-03-31$180.00M
10-Q · filed 2020-05-04
$318.00M
derived: sum of 2 quarters · filed 2021-02-22
$544.00M
derived: sum of 3 quarters · filed 2021-02-22
$763.00M
derived: sum of 4 quarters · filed 2021-02-22
2018-12-31$138.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22
$364.00M
derived: sum of 2 quarters · filed 2021-02-22
$583.00M
derived: sum of 3 quarters · filed 2021-02-22
$779.00M
10-K · filed 2021-02-22
2018-09-30$226.00M
10-Q · filed 2019-10-23
$445.00M
derived: sum of 2 quarters · filed 2019-10-23
$641.00M
10-Q · filed 2019-10-23
$908.00M
derived: sum of 4 quarters · filed 2020-02-20
2018-06-30$219.00M
10-Q · filed 2019-07-24
$415.00M
10-Q · filed 2019-07-24
$682.00M
derived: sum of 3 quarters · filed 2020-02-20
$869.00M
derived: sum of 4 quarters · filed 2020-02-20
2018-03-31$196.00M
10-Q · filed 2019-04-24
$463.00M
derived: sum of 2 quarters · filed 2020-02-20
$650.00M
derived: sum of 3 quarters · filed 2020-02-20
$865.00M
derived: sum of 4 quarters · filed 2020-02-20
2017-12-31$267.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20
$454.00M
derived: sum of 2 quarters · filed 2020-02-20
$669.00M
derived: sum of 3 quarters · filed 2020-02-20
$848.00M
10-K · filed 2020-02-20
2017-09-30$187.00M
10-Q · filed 2018-10-24
$402.00M
derived: sum of 2 quarters · filed 2018-10-24
$581.00M
10-Q · filed 2018-10-24
$737.00M
derived: sum of 4 quarters · filed 2019-02-21
2017-06-30$215.00M
10-Q · filed 2018-07-25
$394.00M
10-Q · filed 2018-07-25
$550.00M
derived: sum of 3 quarters · filed 2019-02-21
$750.00M
derived: sum of 4 quarters · filed 2019-02-21
2017-03-31$179.00M
10-Q · filed 2018-04-20
$335.00M
derived: sum of 2 quarters · filed 2019-02-21
$535.00M
derived: sum of 3 quarters · filed 2019-02-21
$728.00M
derived: sum of 4 quarters · filed 2019-02-21
2016-12-31$156.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21
$356.00M
derived: sum of 2 quarters · filed 2019-02-21
$549.00M
derived: sum of 3 quarters · filed 2019-02-21
$662.00M
10-K · filed 2019-02-21
2016-09-30$200.00M
10-Q · filed 2017-10-19
$393.00M
derived: sum of 2 quarters · filed 2017-10-19
$506.00M
10-Q · filed 2017-10-19
$699.00M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$193.00M
10-Q · filed 2017-07-25
$306.00M
10-Q · filed 2017-07-25
$499.00M
derived: sum of 3 quarters · filed 2018-02-23
$847.00M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$113.00M
10-Q · filed 2017-04-21
$112.00M
10-Q · filed 2016-04-27
$306.00M
derived: sum of 2 quarters · filed 2018-02-23
$654.00M
derived: sum of 3 quarters · filed 2018-02-23
$788.00M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$193.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$541.00M
derived: sum of 2 quarters · filed 2018-02-23
$675.00M
derived: sum of 3 quarters · filed 2018-02-23
$742.00M
10-K · filed 2018-02-23
2015-09-30$348.00M
10-Q · filed 2016-10-21
$482.00M
derived: sum of 2 quarters · filed 2016-10-21
$549.00M
10-Q · filed 2016-10-21
$737.00M
derived: sum of 4 quarters · filed 2017-02-22
2015-06-30$134.00M
10-Q · filed 2016-07-25
$201.00M
10-Q · filed 2016-07-25
$389.00M
derived: sum of 3 quarters · filed 2017-02-22
$521.00M
derived: sum of 4 quarters · filed 2017-02-22
2015-03-31$67.00M
10-Q · filed 2016-04-27
$255.00M
derived: sum of 2 quarters · filed 2017-02-22
$387.00M
derived: sum of 3 quarters · filed 2017-02-22
$532.00M
derived: sum of 4 quarters · filed 2017-02-22
2014-12-31$188.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22
$320.00M
derived: sum of 2 quarters · filed 2017-02-22
$465.00M
derived: sum of 3 quarters · filed 2017-02-22
$573.00M
10-K · filed 2017-02-22
2014-09-30$132.00M
10-Q · filed 2015-10-29
$277.00M
derived: sum of 2 quarters · filed 2015-10-29
$385.00M
10-Q · filed 2015-10-29
$536.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$145.00M
10-Q · filed 2015-07-30
$253.00M
10-Q · filed 2015-07-30
$404.00M
derived: sum of 3 quarters · filed 2016-02-26
$823.00M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$108.00M
10-Q · filed 2015-04-30
$259.00M
derived: sum of 2 quarters · filed 2016-02-26
$678.00M
derived: sum of 3 quarters · filed 2016-02-26
$829.00M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$151.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$570.00M
derived: sum of 2 quarters · filed 2016-02-26
$721.00M
derived: sum of 3 quarters · filed 2016-02-26
$861.00M
10-K · filed 2016-02-26
2013-09-30$419.00M
10-Q · filed 2014-10-30
$418.65M
10-Q · filed 2013-10-24
$570.00M
derived: sum of 2 quarters · filed 2014-10-30
$710.00M
10-Q · filed 2014-10-30
$709.80M
10-Q · filed 2013-10-24
$775.44M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$151.00M
10-Q · filed 2014-07-31
$151.76M
10-Q · filed 2013-07-25
$291.00M
10-Q · filed 2014-07-31
$291.15M
10-Q · filed 2013-07-25
$356.44M
derived: sum of 3 quarters · filed 2015-02-24
$550.31M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$140.00M
10-Q · filed 2014-05-01
$139.39M
10-Q · filed 2013-04-24
$205.44M
derived: sum of 2 quarters · filed 2015-02-24
$399.31M
derived: sum of 3 quarters · filed 2015-02-24
$566.86M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31$65.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$259.31M
derived: sum of 2 quarters · filed 2015-02-24
$426.86M
derived: sum of 3 quarters · filed 2015-02-24
$614.00M
10-K · filed 2015-02-24
$614.52M
10-K · filed 2013-02-27
2012-09-30$193.88M
10-Q · filed 2013-10-24
$361.42M
derived: sum of 2 quarters · filed 2013-10-24
$548.56M
10-Q · filed 2013-10-24
$744.87M
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30$167.54M
10-Q · filed 2013-07-25
$354.69M
10-Q · filed 2013-07-25
$551.00M
derived: sum of 3 quarters · filed 2014-02-18
$693.40M
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31$187.14M
10-Q · filed 2013-04-24
$383.45M
derived: sum of 2 quarters · filed 2014-02-18
$525.86M
derived: sum of 3 quarters · filed 2014-02-18
$699.22M
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31$196.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$338.72M
derived: sum of 2 quarters · filed 2014-02-18
$512.08M
derived: sum of 3 quarters · filed 2014-02-18
$487.00M
10-K · filed 2014-02-18
2011-09-30$142.41M
10-Q · filed 2012-10-24
$315.77M
derived: sum of 2 quarters · filed 2012-10-24
$290.69M
10-Q · filed 2012-10-24
2011-06-30$173.36M
10-Q · filed 2012-07-26
$148.28M
10-Q · filed 2012-07-26
2011-03-31-$25.08M
10-Q · filed 2012-04-27
2010-12-31$788.60M
10-K · filed 2013-02-27
$789.00M
10-K · filed 2011-02-16
2009-12-31$813.00M
10-K · filed 2012-02-16
2008-12-31$520.00M
10-K · filed 2011-02-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30